These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 552853)

  • 1. Dose and sex related effects of benserazide on prolactin secretion.
    Murialdo G; Masturzo P; Carolei A; Polleri A
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):373-7. PubMed ID: 552853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the inhibition of aromatic aminoacids decarboxylase on prolactin secretion in humans.
    Masturzo P; Murialdo G; Carolei A; Polleri A
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):366-72. PubMed ID: 552852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans.
    Polleri A; Masturzo P; Murialdo G; Carolei A
    Acta Endocrinol (Copenh); 1980 Jan; 93(1):7-12. PubMed ID: 7355667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary hormone secretion after inhibition of L-aromatic amino acid decarboxylase activity in man.
    Delitala G; Devilla L; Pende A
    Acta Endocrinol (Copenh); 1980 Dec; 95(4):438-43. PubMed ID: 7456974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benserazide effects on growth hormone, prolactin, and thyrotropin in normal and acromegalic man.
    Masturzo P; De Maria A; Murialdo G; Bonura ML; Zauli C; Polleri A
    J Clin Endocrinol Metab; 1985 Aug; 61(2):378-81. PubMed ID: 4008612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of benserazide administration on prolactin secretion].
    Masturzo P; Murialdo G; Gallamini A; Nizzo MC; Magnani G
    Boll Soc Ital Biol Sper; 1978 Feb; 54(3):274-8. PubMed ID: 687436
    [No Abstract]   [Full Text] [Related]  

  • 7. Benserazide induces migraine attacks. Irrelevance of concomitant hyperprolactinemia.
    Polleri A; Murialdo G; Martignoni E; Nappi G; Savoldi F
    Farmaco Sci; 1979 May; 34(5):465-8. PubMed ID: 554794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin.
    van Praag HM; Korf J; Lequin RM
    Psychopharmacol Commun; 1976; 2(5-6):369-78. PubMed ID: 1088302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary excretion of 3,4-dihydroxyphenyl-alanine, 3-O-methyldopa, dopamine and homovanillic acid in man. Effects of an inhibitor of decarboxylase of aromatic amino acids (Benserazide) (author's transl)].
    Geissbühler F; Widmer J
    J Clin Chem Clin Biochem; 1976 Nov; 14(11):543-7. PubMed ID: 1003116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic and pharmacodynamic aspects of L-DOPA treatment and dopadecarboxilase inhibitors and dopaminergic antagonists in Parkinson's disease (author's transl)].
    García de Yébenes J; Avila C; Bazán E; García E; Gervás J; Maseda C; Mena M; Muradas V; Ramos JA
    Med Clin (Barc); 1982 Apr; 78(7):259-64. PubMed ID: 7087591
    [No Abstract]   [Full Text] [Related]  

  • 11. Benserazide, a stimulator of prolactin release: a new test in the diagnosis of pituitary prolactin-secreting tumours.
    Pontiroli AE; Falsetti L; Voltolini AM; Alberetto M; Pellicciotta G; de Pasqua A; Girardi AM; Pozza G
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):326-32. PubMed ID: 7293664
    [No Abstract]   [Full Text] [Related]  

  • 12. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P; Enjaume P; Dutau G; Ribot C; Augier D
    Arch Fr Pediatr; 1976 Jan; 33(1):55-66. PubMed ID: 985031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH and prolactin stimulation by the decarboxylase inhibitor benserazide in primary hypothyroidism.
    Delitala G; Devilla L; Lotti G
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):313-6. PubMed ID: 7389157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the reproducibility of human prolactin response to sulpiride, benserazide, insulin hypoglycaemia and arginine infusion.
    Pontiroli AE; Gala RR; Pellicciotta G; De Pasqua A; Girardi AM; Pozza G
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):410-20. PubMed ID: 474034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of counteracting effect of liposomes on benserazide-induced hyperprolactinemia.
    Murialdo G; Masturzo P; Polleri A; Carolei A; Toffano G
    Neuropsychobiology; 1979; 5(6):317-21. PubMed ID: 503305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.
    Shimamura M; Shimizu M; Yagami T; Funabashi T; Kimura F; Kuroiwa Y; Misu Y; Goshima Y
    Neuropharmacology; 2006 Jun; 50(8):909-16. PubMed ID: 16504219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
    Cavagnini F; Pontiroli AE; Raggi U; Peracchi M; Malinverni A
    Folia Endocrinol; 1973 Dec; 26(6):483-9. PubMed ID: 4801258
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
    Silva MA; Mattern C; Häcker R; Tomaz C; Huston JP; Schwarting RK
    Synapse; 1997 Dec; 27(4):294-302. PubMed ID: 9372552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic drugs improve human visual contrast sensitivity.
    Domenici L; Trimarchi C; Piccolino M; Fiorentini A; Maffei L
    Hum Neurobiol; 1985; 4(3):195-7. PubMed ID: 4066428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.